骨生長刺激植入裝置的全球市場 (2018-2028年):類型·用途·終端用戶·各地區的產業規模·佔有率·趨勢·機會·預測
市場調查報告書
商品編碼
1174481

骨生長刺激植入裝置的全球市場 (2018-2028年):類型·用途·終端用戶·各地區的產業規模·佔有率·趨勢·機會·預測

Bone Growth Stimulator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type, By Application, By End User, By Region

出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球骨生長刺激植入裝置的市場在2023年到2027年的預測期間內將以高年複合成長率成長。

全球骨病發病率的上升以及人口增長預計將在預測期內產生有利的增長。

骨質疏鬆症是導致骨折的主要疾病之一。此外,預計骨關節炎患病率的增加也將在預測期內推動市場增長。此外,全球傷害和事故發生率的增加也被認為是可能提振市場需求的主要因素之一。

本報告提供全球骨生長刺激植入裝置的市場調查,彙整市場概要,市場規模及市場佔有率的轉變·預測,各種區分·地區/各主要國家的詳細分析,市場的各種影響因素的分析,競爭環境,主要企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 VOC (客戶的迴響)

第5章 全球骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型 (外部骨生長刺激植入裝置·超音波骨生長刺激植入裝置·移植骨生長刺激植入裝置)
    • 各用途 (脊椎融合手術·癒合延遲骨折·非癒合骨折·口腔顎顏面外科·其他)
    • 各終端用戶 (醫院及門診病人手術中心·居家醫療·學術及研究機關)
    • 各地區
    • 各企業
  • 市場地圖

第6章 北美的骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第7章 歐洲的骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第8章 亞太地區的骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第9章 南美的骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第10章 中東·非洲的骨生長刺激植入裝置市場展望

  • 市場規模·預測
  • 市場佔有率·預測
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢·展開

  • 近幾年的進步
  • 產品的銷售
  • M&A

第13章 全球骨生長刺激植入裝置市場:SWOT分析

第14章 波特的五力分析

第15章 競爭情形

  • 產業概要
  • 提供產品
  • 近幾年的發展
  • 財務
  • 主要人事
  • SWOT分析
    • Colfax Corporation.
    • Arthrex.
    • Essex Woodlands Healthcare Partners.
    • Isto Biologics.
    • JOHNSON and JOHNSON.
    • Medtronic Plc.
    • Orthofix Medical Inc.
    • Stryker Corporation.
    • Terumo Corporation
    • Zimmer Biomet Holdings.
    • Manamed Inc.
    • Theragen Etex Co. Ltd.

第16章 策略性建議

簡介目錄
Product Code: 14321

Global bone growth stimulator market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period. Besides, growing technological advancement in bone growth stimulators and the growing adoption rate for bone growth stimulators by patients and healthcare providers are major factors boosting the market's growth over the years.

Growing Prevalence of Bone Disorders

The growing occurrence of bone diseases across the globe due to the increasing population is expected to create lucrative growth during the forecast period. Osteoporosis is one of the major diseases that cause fractures across the globe which anticipated the growth of the bone growth stimulator market over the years. More than 8.9 million fractures annually happen and affect around 75 million people in the U.S. In addition, increasing prevalence of osteoarthritis is also expected to boost the market's growth during the forecast period. The rise in the prevalence and burden of orthopedic diseases has increased the patient pool undergoing minimally invasive surgeries across the globe. So, the demand for bone growth stimulators has increased rapidly. Similarly, the high prevalence of bone marrow transplants and bone cancers adds to the demand for the bone growth stimulator market during the forecast period. The American Cancer Society estimates that cases of primary cancer of the bones and joints for 2022, include 3,910 newly diagnosed cases and about 2,100 deaths. Furthermore, an increasing incidence of trauma and accident cases worldwide is considered one of the major factors likely to boost the demand for the market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, the above-mentioned factors explain that the bone growth stimulator market is expected to witness significant growth over the forecast period globally.

Growing research and development activities

Increasing efforts from different manufacturers to develop novel and innovative technologically advanced products in the market will significantly boost the market growth during the forecast period. Similarly, the rapid adoption of advanced technology is expected to create lucrative growth during the forecast period. For instance, in March 2016, Bioventus LLC launched its ultrasound bone healing stimulator system. Additionally, increasing demand for minimally invasive surgeries is increasing because of patient benefits like painless treatment, reduced postoperative hospital stay, reduced surgical trauma, surgical risks reduced, improved patient care, and greater affordability is improving the demand for bone growth stimulator market across the globe during the forecast period. According to National Spinal Cord Injury Statistical Centre's statistics, there are 17,730 new cases of spinal cord injury reported annually, and between 249,000 and 363,000 Americans are estimated to be living with a spinal cord injury.

Market Segmentation

The global bone growth stimulator market can be segmented by type, application, end-user, and region. Based on type, the market can be segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, and Implanted Bone Growth Stimulators. Based on application, the market can be grouped into Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, and Others. Based on end users, the market can be segmented into Hospital and Ambulatory Surgery Centers, Home Care Settings, and Academic and Research Institutes. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among these different countries, the United States dominated the global bone growth stimulator market on account of the growing demand for minimally invasive surgeries with low costs for the treatment of bone-related diseases.

Market Players

Colfax Corporation., Arthrex., Essex Woodlands Healthcare Partners., Isto Biologics., JOHNSON and JOHNSON., Medtronic Plc., Orthofix Medical Inc., Stryker Corporation., Terumo Corporation, Zimmer Biomet Holdings., Manamed Inc., Theragen Etex Co. Ltd. are some of the leading players operating in the Global Bone Growth Stimulators Market.

Report Scope

In this report, the global bone growth stimulator market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Growth Stimulator Market, By Type:

  • External Bone Growth Stimulators
  • Ultrasonic Bone Growth Stimulators
  • Implanted Bone Growth Stimulators

Bone Growth Stimulator Market, By Application:

  • Spinal Fusion Surgeries
  • Delayed Union, and Non-union Bone Fractures
  • Oral and Maxillofacial Surgeries
  • Others

Bone Growth Stimulator Market, By End Users:

  • Hospital and Ambulatory Surgery Centers
  • Home Care Settings
  • Academic and Research Institutes

Bone Growth Stimulator Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Growth Stimulator Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Growth Stimulator Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 5.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 5.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Bone Growth Stimulator Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 6.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 6.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bone Growth Stimulator Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bone Growth Stimulator Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bone Growth Stimulator Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bone Growth Stimulator Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 7.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 7.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Bone Growth Stimulator Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Bone Growth Stimulator Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bone Growth Stimulator Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bone Growth Stimulator Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bone Growth Stimulator Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Bone Growth Stimulator Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 8.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 8.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Bone Growth Stimulator Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bone Growth Stimulator Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bone Growth Stimulator Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bone Growth Stimulator Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bone Growth Stimulator Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Bone Growth Stimulator Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 9.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 9.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Bone Growth Stimulator Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Bone Growth Stimulator Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Bone Growth Stimulator Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Bone Growth Stimulator Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
    • 10.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
    • 10.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Bone Growth Stimulator Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Bone Growth Stimulator Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Bone Growth Stimulator Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Advancements
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Bone Growth Stimulators Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1. Colfax Corporation.
    • 15.6.2. Arthrex.
    • 15.6.3. Essex Woodlands Healthcare Partners.
    • 15.6.4. Isto Biologics.
    • 15.6.5. JOHNSON and JOHNSON.
    • 15.6.6. Medtronic Plc.
    • 15.6.7. Orthofix Medical Inc.
    • 15.6.8. Stryker Corporation.
    • 15.6.9. Terumo Corporation
    • 15.6.10. Zimmer Biomet Holdings.
    • 15.6.11. Manamed Inc.
    • 15.6.12. Theragen Etex Co. Ltd.

16. Strategic Recommendations